Impact of Infusion Timing on Safety and Efficacy of Anti-CD19 and Anti-BCMA CAR T Therapies

Key Points

• Infusion timing significantly impacts the efficacy of CAR T therapies, enhancing patient outcomes.
• The analysis observed a notable increase in efficacy rates with optimal infusion timing during treatment.
• This observational analysis evaluated the timing of anti-CD19 and anti-BCMA CAR T therapies.
• Findings highlight the importance of infusion timing in optimizing clinical outcomes.